anonymous
Guest
anonymous
Guest
We are finally feeling the pain of being under Valeant who only cares about the mighty dollar and only profiting for the sake of trying to save their ass. Sales are down across the country and offices are finally saying enough is enough. They are tired of pharma greed and looking at eliminating Arestin all together. It is sad that the only reason they are eliminating it is because OraPharma has based their business model off insurance coverage and greed and not the customer or the patient. Insurance is now failing and now we are in a place I warned about years ago, but sadly wasn't allowed to speak my ideas or thoughts. Burning our customers is at a point of no return. I give it a year till we are sadly in a catalog and put on a shelf next to periochip.